DeLyons Ron 4
Research Summary
AI-generated summary
Chemed (CHE) Director Ron DeLyons Receives Stock Award
What Happened
- Ron DeLyons, a director of Chemed Corp (CHE), was granted 386 shares as a stock award on May 18, 2026. The award is reported at $440.77 per share, for a total reported value of $170,137. This was an award/grant (compensation), not an open-market purchase or sale.
Key Details
- Transaction date and price: May 18, 2026 — 386 shares at $440.77 per share (total $170,137).
- Transaction type: Award/Grant (SEC code A). Footnote F1: "Award of stock."
- Shares owned after transaction: Not specified in the filing.
- Filing timeliness: Form filed May 19, 2026 (one day after the transaction) — appears to be timely.
- No sale, exercise, or 10b5-1 plan noted; no tax withholding or disposition reported in this filing.
Context
- Stock awards to directors are a common form of compensation intended for alignment with shareholders; they are routine and do not by themselves indicate a personal purchase conviction.
- For retail investors, outright purchases typically carry more immediate interpretive weight than awards; treat this as compensation disclosure rather than a market signal.